These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
665 related items for PubMed ID: 18460666
1. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ, Active Bacterial Core surveillance/Emerging Infections Program Network. JAMA; 2008 May 07; 299(17):2056-65. PubMed ID: 18460666 [Abstract] [Full Text] [Related]
2. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. N Engl J Med; 2000 Jan 06; 342(1):15-20. PubMed ID: 10620644 [Abstract] [Full Text] [Related]
3. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ, Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC. Pediatr Infect Dis J; 2008 Dec 06; 27(12):1057-64. PubMed ID: 18989238 [Abstract] [Full Text] [Related]
4. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ. JAMA Pediatr; 2019 Mar 01; 173(3):224-233. PubMed ID: 30640366 [Abstract] [Full Text] [Related]
5. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA. J Infect Dis; 2000 Jul 01; 182(1):168-73. PubMed ID: 10882594 [Abstract] [Full Text] [Related]
6. Evaluation of universal antenatal screening for group B streptococcus. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ. N Engl J Med; 2009 Jun 18; 360(25):2626-36. PubMed ID: 19535801 [Abstract] [Full Text] [Related]
7. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease Control and Prevention (CDC). MMWR Suppl; 2014 Oct 31; 63(4):3-27. PubMed ID: 25356673 [Abstract] [Full Text] [Related]
8. Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015. Sigaúque B, Kobayashi M, Vubil D, Nhacolo A, Chaúque A, Moaine B, Massora S, Mandomando I, Nhampossa T, Bassat Q, Pimenta F, Menéndez C, Carvalho MDG, Macete E, Schrag SJ. PLoS One; 2018 Oct 31; 13(1):e0191193. PubMed ID: 29351318 [Abstract] [Full Text] [Related]
9. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT. Lancet; 2012 Feb 11; 379(9815):547-56. PubMed ID: 22226047 [Abstract] [Full Text] [Related]
10. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. Stafford IA, Stewart RD, Sheffield JS, Wendel GD, Sanchez PJ, McIntire DD, Roberts SW. Obstet Gynecol; 2012 Jul 11; 120(1):123-9. PubMed ID: 22914400 [Abstract] [Full Text] [Related]
11. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study. Carreras-Abad C, Cochet M, Hall T, Ramkhelawon L, Khalil A, Peregrine E, Vinayakarao L, Sivarajan S, Hamid R, Planche T, Sheridan E, Winchester S, Plumb J, Djennad A, Andrews N, Le Doare K, Heath P. Health Technol Assess; 2019 Dec 11; 23(67):1-40. PubMed ID: 31855555 [Abstract] [Full Text] [Related]
12. Early-onset group B streptococcal disease in the era of maternal screening. Puopolo KM, Madoff LC, Eichenwald EC. Pediatrics; 2005 May 11; 115(5):1240-6. PubMed ID: 15867030 [Abstract] [Full Text] [Related]
13. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, Flores AE, Ferrieri P, Baker CJ. Clin Infect Dis; 2000 Feb 11; 30(2):276-81. PubMed ID: 10671328 [Abstract] [Full Text] [Related]
14. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Schrag SJ, Verani JR. Vaccine; 2013 Aug 28; 31 Suppl 4():D20-6. PubMed ID: 23219695 [Abstract] [Full Text] [Related]
15. Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2007 Jul 20; 56(28):701-5. PubMed ID: 17637595 [Abstract] [Full Text] [Related]
16. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, Efstratiou A. Clin Infect Dis; 2004 May 01; 38(9):1203-8. PubMed ID: 15127328 [Abstract] [Full Text] [Related]
17. Group B streptococcal disease in infants: progress in prevention and continued challenges. Verani JR, Schrag SJ. Clin Perinatol; 2010 Jun 01; 37(2):375-92. PubMed ID: 20569813 [Abstract] [Full Text] [Related]
18. Epidemiology of invasive group B streptococcal disease in infants from urban area of South China, 2011-2014. Guan X, Mu X, Ji W, Yuan C, He P, Zhang L, Huang Y, Li J, Chen J, Zhong H, Pang S, Tan N, Deng Q, Gao K, Huang YP, Chang CY, Liu H. BMC Infect Dis; 2018 Jan 08; 18(1):14. PubMed ID: 29310577 [Abstract] [Full Text] [Related]
19. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily P, Apostol M, Petit S, Farley M, Lynfield R, Reingold A, Hansen NI, Stoll BJ, Shane AL, Zell E, Schrag SJ. Pediatr Infect Dis J; 2011 Nov 08; 30(11):937-41. PubMed ID: 21654548 [Abstract] [Full Text] [Related]
20. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Lamagni TL, Keshishian C, Efstratiou A, Guy R, Henderson KL, Broughton K, Sheridan E. Clin Infect Dis; 2013 Sep 08; 57(5):682-8. PubMed ID: 23845950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]